First Time Loading...
T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 10.09 CNY -0.88% Market Closed
Updated: May 5, 2024

Tonghua Dongbao Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tonghua Dongbao Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
T
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Operating Income
¥1.3B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
19%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Operating Income
¥787.7m
CAGR 3-Years
32%
CAGR 5-Years
24%
CAGR 10-Years
N/A

See Also

What is Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income?
Operating Income
1.3B CNY

Based on the financial report for Dec 31, 2023, Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income amounts to 1.3B CNY.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
19%

Over the last year, the Operating Income growth was 43%. The average annual Operating Income growth rates for Tonghua Dongbao Pharmaceutical Co Ltd have been 4% over the past three years , 5% over the past five years , and 19% over the past ten years .